- Home
- NCTY vs SCPH Comparison
NCTY vs SCPH Comparison
Compare NCTY & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCTY
- SCPH
- Stock Information
- Founded
- NCTY 1999
- SCPH 2013
- Country
- NCTY China
- SCPH United States
- Employees
- NCTY N/A
- SCPH N/A
- Industry
- NCTY Business Services
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- NCTY Consumer Discretionary
- SCPH Health Care
- Exchange
- NCTY Nasdaq
- SCPH Nasdaq
- Market Cap
- NCTY 156.7M
- SCPH 173.6M
- IPO Year
- NCTY 2004
- SCPH 2017
- Fundamental
- Price
- NCTY $9.36
- SCPH $3.64
- Analyst Decision
- NCTY
- SCPH Strong Buy
- Analyst Count
- NCTY 0
- SCPH 3
- Target Price
- NCTY N/A
- SCPH $14.00
- AVG Volume (30 Days)
- NCTY 89.6K
- SCPH 423.8K
- Earning Date
- NCTY 01-01-0001
- SCPH 05-14-2025
- Dividend Yield
- NCTY N/A
- SCPH N/A
- EPS Growth
- NCTY N/A
- SCPH N/A
- EPS
- NCTY N/A
- SCPH N/A
- Revenue
- NCTY $15,305,175.00
- SCPH $41,982,000.00
- Revenue This Year
- NCTY N/A
- SCPH $109.32
- Revenue Next Year
- NCTY N/A
- SCPH $76.95
- P/E Ratio
- NCTY N/A
- SCPH N/A
- Revenue Growth
- NCTY N/A
- SCPH 138.10
- 52 Week Low
- NCTY $5.75
- SCPH $1.94
- 52 Week High
- NCTY $20.59
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- NCTY 32.45
- SCPH 66.63
- Support Level
- NCTY $11.21
- SCPH $3.23
- Resistance Level
- NCTY $11.95
- SCPH $3.74
- Average True Range (ATR)
- NCTY 0.75
- SCPH 0.31
- MACD
- NCTY -0.21
- SCPH 0.08
- Stochastic Oscillator
- NCTY 8.21
- SCPH 93.81
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.